Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19714757 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Ulcerative Colitis Study: Study of Visilizumab in Patients With Severe Ulcerative Colitis
Condition: Severe Ulcerative Colitis
Intervention: Drug: Visilizumab

Indicates status has not been verified in more than two years